Kynurenine pathway metabolites selectively associate with impaired associative memory function in depression

[1]  D. Goldsmith,et al.  Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression , 2020, Neuropsychopharmacology.

[2]  Henrik Zetterberg,et al.  Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer's disease and relationship to amyloid-β and tau , 2019, Neurobiology of Aging.

[3]  Y. Ning,et al.  Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder , 2019, Psychoneuroendocrinology.

[4]  D. Aarsland,et al.  The kynurenine pathway and cognitive performance in community-dwelling older adults. The Hordaland Health Study , 2019, Brain, Behavior, and Immunity.

[5]  M. Zhang,et al.  Kynurenine pathway changes in late-life depression with memory deficit , 2018, Psychiatry Research.

[6]  L. Tozzi,et al.  Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes , 2018, Psychoneuroendocrinology.

[7]  Y. Iwata,et al.  Kynurenine pathway in depression: A systematic review and meta-analysis , 2018, Neuroscience & Biobehavioral Reviews.

[8]  L. Vécsei,et al.  Mitochondria, Oxidative Stress and the Kynurenine System, with a Focus on Ageing and Neuroprotection , 2018, Molecules.

[9]  E. Vieta,et al.  Treatment of neurocognitive symptoms in unipolar depression: A systematic review and future perspectives. , 2017, Journal of affective disorders.

[10]  B. Cuthbert.  Research Domain Criteria: cognitive systems, neural circuits, and dimensions of behaviour , 2017 .

[11]  C. Bird,et al.  The role of the hippocampus in recognition memory , 2017, Cortex.

[12]  Grit Herzmann,et al.  Neural correlates of memory encoding and recognition for own-race and other-race faces in an associative-memory task , 2017, Brain Research.

[13]  Kymberly D. Young,et al.  Kynurenine pathway metabolites are associated with hippocampal activity during autobiographical memory recall in patients with depression , 2016, Brain, Behavior, and Immunity.

[14]  R. Dantzer.  Role of the Kynurenine Metabolism Pathway in Inflammation-Induced Depression: Preclinical Approaches. , 2016, Current topics in behavioral neurosciences.

[15]  M. Fakhoury.  Immune-mediated processes in neurodegeneration: where do we stand? , 2016, Journal of Neurology.

[16]  A. Carvalho,et al.  Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: Evidences from animal and human studies. , 2015, Journal of psychiatric research.

[17]  Teresa A. Victor,et al.  Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder , 2015, Brain, Behavior, and Immunity.

[18]  R. Carter,et al.  Dentate gyrus volume and memory performance in major depressive disorder. , 2015, Journal of affective disorders.

[19]  T. Stone,et al.  The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders , 2013, British journal of pharmacology.

[20]  C. Cunningham.  Microglia and neurodegeneration: The role of systemic inflammation , 2013, Glia.

[21]  P. de Jonge,et al.  Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study , 2010, Psychological Medicine.

[22]  M. Trivedi,et al.  Defining and Measuring Functional , 2010, CNS drugs.

[23]  Denise C. Park,et al.  A lifespan database of adult facial stimuli , 2004, Behavior research methods, instruments, & computers : a journal of the Psychonomic Society, Inc.

[24]  J. Markowitz,et al.  The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression , 2003, Biological Psychiatry.

[25]  H Stanislaw,et al.  Calculation of signal detection theory measures , 1999, Behavior research methods, instruments, & computers : a journal of the Psychonomic Society, Inc.

[26]  S. Baxendale.  The role of the hippocampus in recognition memory , 1997, Neuropsychologia.

[27]  A. Rush,et al.  The Inventory of Depressive Symptomatology (IDS): psychometric properties , 1996, Psychological Medicine.

[28]  Teresa A. Victor,et al.  Putative Neuroprotective and Neurotoxic Kynurenine Pathway Metabolites Are Associated with Hippocampal and Amygdalar Volumes in Subjects with Major Depressive Disorder , 2015, Neuropsychopharmacology.

[29]  M. Trivedi,et al.  Cognitive dysfunction in unipolar depression: implications for treatment. , 2014, Journal of affective disorders.

[30]  M. Husain,et al.  Association between depression severity and neurocognitive function in major depressive disorder: a review and synthesis. , 2010, Neuropsychology.

[31]  R. Dantzer,et al.  From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.

[32]  R. Dantzer,et al.  Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy , 2002, Molecular Psychiatry.